Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia

Background: Adults with Down syndrome (DS) are at increased risk for dementia and provide an opportunity to identify patterns of brain activity that may precede dementia. Studies of early Alzheimer’s disease (AD) and risk of AD show decreased function in posterior cingulate and temporal cortex as initial indicators of the disease process, but whether the origin and sequence of predementia brain changes are the same in DS is unknown. Methods: The regional cerebral glucose metabolic rates (GMR) among middle-aged nondemented people with DS (n = 17), people with moderate AD (n = 10), and age-matched control subjects (n = 24) were compared using PET during a cognitive task. Results: Statistical parametric mapping conjunction analyses showed that 1) both DS and AD groups had lower GMR than their respective controls primarily in posterior cingulate and 2) compared with respective controls, the subjects with DS had higher GMR in the same areas of inferior temporal/entorhinal cortex where the AD subjects had lower GMR. The same results were replicated after 1 year of follow-up. Conclusions: As the DS subjects were not clinically demented, inferior temporal/entorhinal cortex hypermetabolism may reflect a compensatory response early in disease progression. Compensatory responses may subsequently fail, leading to neurodegenerative processes that the authors anticipate will be detectable in vivo as future GMR decreases in inferior temporal/entorhinal cortex are accompanied by clinical signs of dementia.

[1]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[2]  M. Bobinski,et al.  Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.

[3]  C. Grady,et al.  Down's syndrome in adults: brain metabolism. , 1983, Science.

[4]  G. Alexander,et al.  Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  N. Schupf,et al.  Prevalence of dementia in adults with and without Down syndrome. , 1996, American journal of mental retardation : AJMR.

[6]  N. Cairns,et al.  Increased glyceraldehyde 3-phosphate dehydrogenase levels in the brain of patients with Down's syndrome , 1999, Neuroscience Letters.

[7]  S. Deb,et al.  Comparison of rating scales for the diagnosis of dementia in adults with Down's syndrome. , 2001, Journal of intellectual disability research : JIDR.

[8]  N. Foster,et al.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[9]  A. Huxley,et al.  The dementia scale for Down's syndrome. , 2000, Journal of intellectual disability research : JIDR.

[10]  Karl J. Friston,et al.  Statistical parametric maps in functional imaging: A general linear approach , 1994 .

[11]  N. Cairns,et al.  Impaired brain glucose metabolism in patients with Down syndrome. , 1999, Journal of neural transmission. Supplementum.

[12]  H. Evenhuis,et al.  Further evaluation of the Dementia Questionnaire for Persons with Mental Retardation (DMR). , 1996, Journal of intellectual disability research : JIDR.

[13]  M. Buchsbaum,et al.  Cortical glucose metabolic rate correlates of abstract reasoning and attention studied with positron emission tomography , 1988 .

[14]  Richard J. Haier,et al.  Brain size and cerebral glucose metabolic rate in nonspecific mental retardation and down syndrome , 1995 .

[15]  C. Cotman,et al.  Parallel Compensatory and Pathological Events Associated with Tau Pathology in Middle Aged Individuals with Down Syndrome , 2003, Journal of neuropathology and experimental neurology.

[16]  P Pietrini,et al.  Brain cognition and metabolism in Down syndrome adults in association with development of dementia , 1996, Neuroreport.

[17]  A. Smith,et al.  Imaging the progression of Alzheimer pathology through the brain , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  N L Foster,et al.  Discordance between Traditional Pathologic and Energy Metabolic Changes in Very Early Alzheimer's Disease: Pathophysiological Implications , 1999, Annals of the New York Academy of Sciences.

[19]  K. Wisniewski,et al.  Normal ageing in adults with Down's syndrome: a longitudinal study. , 1996, Journal of intellectual disability research : JIDR.

[20]  G. Alexander,et al.  Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. , 2002, The American journal of psychiatry.

[21]  C Oliver,et al.  Down's Syndrome and Alzheimer's disease: a review , 1986, Psychological Medicine.

[22]  F. Fazio,et al.  Impairment of Neocortical Metabolism Predicts Progression in Alzheimer’s Disease , 1999, Dementia and Geriatric Cognitive Disorders.

[23]  P. Bendel,et al.  Altered brain glucose metabolism in transgenic-PFKL mice with elevated l-phosphofructokinase: in vivo NMR studies , 1998, Brain Research.

[24]  M. Mesulam Neuroplasticity Failure in Alzheimer's Disease Bridging the Gap between Plaques and Tangles , 1999, Neuron.

[25]  J V Haxby,et al.  Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia. , 1997, The American journal of psychiatry.

[26]  H. Wiśniewski,et al.  Alzheimer's disease in Down's syndrome , 1985, Neurology.

[27]  J. Haxby,et al.  Regional Cerebral Glucose Metabolism is Normal in Young Adults with down Syndrome , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  M. Bobinski,et al.  Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Karl J. Friston,et al.  Cognitive Conjunction: A New Approach to Brain Activation Experiments , 1997, NeuroImage.

[30]  R. S. Williams,et al.  A prospective study of Alzheimer disease in Down syndrome. , 1989, Archives of neurology.

[31]  E. Head,et al.  Down syndrome and Alzheimer's disease: a link between development and aging. , 2001, Mental retardation and developmental disabilities research reviews.

[32]  J. Talairach,et al.  Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System: An Approach to Cerebral Imaging , 1988 .

[33]  Nick C Fox,et al.  Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  N. Cutler Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-d-glucose: Healthy aging Alzheimer's disease and down syndrome , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[35]  S. Black,et al.  Evidence from Functional Neuroimaging of a Compensatory Prefrontal Network in Alzheimer's Disease , 2003, The Journal of Neuroscience.

[36]  Nick C Fox,et al.  Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images , 2001, The Lancet.

[37]  J. Mazziotta,et al.  Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  S. Thibodeau,et al.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.

[39]  G. Alexander,et al.  Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. , 2001, JAMA.

[40]  Nathan S White,et al.  A voxel-based morphometric study of nondemented adults with Down Syndrome , 2003, NeuroImage.